BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15369398)

  • 21. Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
    Shi W; Ma H; Duan Y; Aubart K; Fang Y; Zonis R; Yang L; Hu W
    Bioorg Med Chem Lett; 2011 Feb; 21(3):1060-3. PubMed ID: 21185180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peptide deformylase as an antibacterial target: a critical assessment.
    Leeds JA; Dean CR
    Curr Opin Pharmacol; 2006 Oct; 6(5):445-52. PubMed ID: 16904375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing.
    Bingel-Erlenmeyer R; Kohler R; Kramer G; Sandikci A; Antolić S; Maier T; Schaffitzel C; Wiedmann B; Bukau B; Ban N
    Nature; 2008 Mar; 452(7183):108-11. PubMed ID: 18288106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isoxazole-3-hydroxamic acid derivatives as peptide deformylase inhibitors and potential antibacterial agents.
    Calí P; Naerum L; Mukhija S; Hjelmencrantz A
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5997-6000. PubMed ID: 15546716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular cloning and characterization of a new peptide deformylase from human pathogenic bacterium Helicobacter pylori.
    Han C; Wang Q; Dong L; Sun H; Peng S; Chen J; Yang Y; Yue J; Shen X; Jiang H
    Biochem Biophys Res Commun; 2004 Jul; 319(4):1292-8. PubMed ID: 15194508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Docking studies of nickel-peptide deformylase (PDF) inhibitors: exploring the new binding pockets.
    Wang Q; Zhang D; Wang J; Cai Z; Xu W
    Biophys Chem; 2006 Jun; 122(1):43-9. PubMed ID: 16545516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acylprolinamides: a new class of peptide deformylase inhibitors with in vivo antibacterial activity.
    Axten JM; Medina JR; Blackledge CW; Duquenne C; Grant SW; Bobko MA; Peng T; Miller WH; Pinckney T; Gallagher TF; Kulkarni S; Lewandowski T; Van Aller GS; Zonis R; Ward P; Campobasso N
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4028-32. PubMed ID: 22579486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New peptide deformylase inhibitors and cooperative interaction: a combination to improve antibacterial activity.
    Goemaere E; Melet A; Larue V; Lieutaud A; Alves de Sousa R; Chevalier J; Yimga-Djapa L; Giglione C; Huguet F; Alimi M; Meinnel T; Dardel F; Artaud I; Pagès JM
    J Antimicrob Chemother; 2012 Jun; 67(6):1392-400. PubMed ID: 22378679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel class of inhibitors of peptide deformylase discovered through high-throughput screening and virtual ligand screening.
    Howard MH; Cenizal T; Gutteridge S; Hanna WS; Tao Y; Totrov M; Wittenbach VA; Zheng YJ
    J Med Chem; 2004 Dec; 47(27):6669-72. PubMed ID: 15615515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptidomimetic inhibitors of bacterial peptide deformylase.
    East SP; Ayscough A; Toogood-Johnson I; Taylor S; Thomas W
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4032-5. PubMed ID: 21621999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of macrocyclic peptidyl hydroxamates as peptide deformylase inhibitors.
    Shen G; Zhu J; Simpson AM; Pei D
    Bioorg Med Chem Lett; 2008 May; 18(10):3060-3. PubMed ID: 18093832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.
    Wiener JJ; Gomez L; Venkatesan H; Santillán A; Allison BD; Schwarz KL; Shinde S; Tang L; Hack MD; Morrow BJ; Motley ST; Goldschmidt RM; Shaw KJ; Jones TK; Grice CA
    Bioorg Med Chem Lett; 2007 May; 17(10):2718-22. PubMed ID: 17382544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a human peptide deformylase: implications for antibacterial drug design.
    Nguyen KT; Hu X; Colton C; Chakrabarti R; Zhu MX; Pei D
    Biochemistry; 2003 Aug; 42(33):9952-8. PubMed ID: 12924944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the origins of time-dependent inhibition by polypeptide deformylase inhibitors.
    Totoritis R; Duraiswami C; Taylor AN; Kerrigan JJ; Campobasso N; Smith KJ; Ward P; King BW; Murrayz-Thompson M; Jones AD; Van Aller GS; Aubart KM; Zalacain M; Thrall SH; Meek TD; Schwartz B
    Biochemistry; 2011 Aug; 50(31):6642-54. PubMed ID: 21711014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for the design of antibiotics targeting peptide deformylase.
    Hao B; Gong W; Rajagopalan PT; Zhou Y; Pei D; Chan MK
    Biochemistry; 1999 Apr; 38(15):4712-9. PubMed ID: 10200158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of 4'-((5-benzylidene-2,4-dioxothiazolidin-3-yl)methyl)biphenyl-2-carbonitrile analogs as bacterial peptide deformylase inhibitors.
    Khan FA; Patil RH; Shinde DB; Sangshetti JN
    Chem Biol Drug Des; 2016 Dec; 88(6):938-944. PubMed ID: 27401234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A series of heterocyclic inhibitors of phenylalanyl-tRNA synthetases with antibacterial activity.
    Yu XY; Finn J; Hill JM; Wang ZG; Keith D; Silverman J; Oliver N
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1343-6. PubMed ID: 14980695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.
    Clements JM; Beckett RP; Brown A; Catlin G; Lobell M; Palan S; Thomas W; Whittaker M; Wood S; Salama S; Baker PJ; Rodgers HF; Barynin V; Rice DW; Hunter MG
    Antimicrob Agents Chemother; 2001 Feb; 45(2):563-70. PubMed ID: 11158755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biphenyl tetrazole-thiazolidinediones as novel bacterial peptide deformylase inhibitors: Synthesis, biological evaluations and molecular docking study.
    Khan FAK; Jadhav KS; Patil RH; Shinde DB; Arote RB; Sangshetti JN
    Biomed Pharmacother; 2016 Oct; 83():1146-1153. PubMed ID: 27551762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
    Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
    J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.